- Filed
- Oct 12, 2022 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2022 · Dec 31, 2021 | 3.81M sh |
| Shares Diluted | Q2 2022 · Nov 30, 2021 | 3.82M sh |
| Shares Diluted | Q2 2022 · Nov 30, 2021 | 3.81M sh |
| Shares Diluted | Q2 2022 · Nov 30, 2020 | 3.76M sh |
| Shares Diluted | Q2 2022 · Nov 30, 2020 | 3.76M sh |
| Capex restated | Q2 2022 · Nov 30, 2021 | $194.43K |
| Capex | Q2 2022 · Nov 30, 2020 | $258.37K |
| Operating Cash Flow restated | Q2 2022 · Nov 30, 2021 | −$4.33M |
| Operating Cash Flow | Q2 2022 · Nov 30, 2020 | −$2.78M |
| Long Term Debt | Q2 2022 · Nov 30, 2021 | $2.59M |
| Long Term Debt | Q2 2022 · May 31, 2021 | $3.25M |
| Short Term Debt | Q2 2022 · Nov 30, 2021 | $876.4K |
| Short Term Debt | Q2 2022 · May 31, 2021 | $541.69K |
| Cash And Equivalents | Q2 2022 · Nov 30, 2021 | $4.57M |
| Cash And Equivalents | Q2 2022 · May 31, 2021 | $4.03M |
| Stockholders Equity restated | Q2 2022 · Nov 30, 2021 | $4.7M |
| Stockholders Equity | Q2 2022 · May 31, 2021 | $3.77M |
| Stockholders Equity | Q2 2022 · Nov 30, 2020 | $9.69M |
| Stockholders Equity | Q2 2022 · May 31, 2020 | $11.89M |
| Current Liabilities restated | Q2 2022 · Nov 30, 2021 | $4.72M |
| Current Liabilities | Q2 2022 · May 31, 2021 | $4.01M |
| Total Liabilities restated | Q2 2022 · Nov 30, 2021 | $18.67M |
| Total Liabilities | Q2 2022 · May 31, 2021 | $17.4M |
| Current Assets restated | Q2 2022 · Nov 30, 2021 | $7.93M |
| Current Assets | Q2 2022 · May 31, 2021 | $6.96M |
| Total Assets restated | Q2 2022 · Nov 30, 2021 | $23.37M |
| Total Assets | Q2 2022 · May 31, 2021 | $21.17M |
| Sga Expense restated | Q2 2022 · Nov 30, 2021 | $3.89M |
| Sga Expense restated | Q2 2022 · Nov 30, 2021 | $8.54M |
| Sga Expense | Q2 2022 · Nov 30, 2020 | $3.09M |
| Sga Expense | Q2 2022 · Nov 30, 2020 | $5.18M |
| Rd Expense | Q2 2022 · Nov 30, 2021 | $5.58K |
| Rd Expense | Q2 2022 · Nov 30, 2021 | $14.85K |
| Rd Expense | Q2 2022 · Nov 30, 2020 | $17.88K |
| Rd Expense | Q2 2022 · Nov 30, 2020 | $35.33K |
| Net Income restated | Q2 2022 · Nov 30, 2021 | $2.48M |
| Net Income restated | Q2 2022 · Nov 30, 2021 | $865.05K |
| Net Income | Q2 2022 · Nov 30, 2020 | −$2.37M |
| Net Income | Q2 2022 · Nov 30, 2020 | −$2.22M |
| Operating Income restated | Q2 2022 · Nov 30, 2021 | −$2.27M |
| Operating Income restated | Q2 2022 · Nov 30, 2021 | −$4.64M |
| Operating Income | Q2 2022 · Nov 30, 2020 | −$2.15M |
| Operating Income | Q2 2022 · Nov 30, 2020 | −$3.77M |
| Gross Profit restated | Q2 2022 · Nov 30, 2021 | $1.62M |
| Gross Profit restated | Q2 2022 · Nov 30, 2021 | $3.91M |
| Gross Profit | Q2 2022 · Nov 30, 2020 | $962.11K |
| Gross Profit | Q2 2022 · Nov 30, 2020 | $1.57M |
| Cost Of Revenue restated | Q2 2022 · Nov 30, 2021 | $1.34M |
| Cost Of Revenue restated | Q2 2022 · Nov 30, 2021 | $2.81M |
| Cost Of Revenue | Q2 2022 · Nov 30, 2020 | $1.07M |
| Cost Of Revenue | Q2 2022 · Nov 30, 2020 | $1.97M |
| Revenue | Q2 2022 · Nov 30, 2021 | $2.96M |
| Revenue | Q2 2022 · Nov 30, 2021 | $6.72M |
| Revenue | Q2 2022 · Nov 30, 2020 | $2.03M |
| Revenue | Q2 2022 · Nov 30, 2020 | $3.54M |